We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+11.52%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.77B
AUM Growth
+$189M
Cap. Flow
-$586M
Cap. Flow %
-15.53%
Top 10 Hldgs %
14.94%
Holding
381
New
11
Increased
47
Reduced
124
Closed
12

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$21.5M
2
VSTS icon
Vestis
VSTS
+$12.8M
3
VLTO icon
Veralto
VLTO
+$5.55M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.47M
5
FA icon
First Advantage
FA
+$5.45M

Sector Composition

Rank Sector Weight
1 Technology 20.04%
2 Industrials 15.65%
3 Financials 13.04%
4 Healthcare 11.52%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBAN icon
226
Huntington Bancshares
HBAN
$35.5B
-95,729
Closed -$996K
MD icon
227
Pediatrix Medical
MD
$2.2B
-823,340
Closed -$10.5M
SGEN
228
DELISTED
Seagen Inc. Common Stock
SGEN
-1,734
Closed -$368K
NIMC
229
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
-24,631
Closed -$2.4M
ATVI
230
DELISTED
Activision Blizzard
ATVI
-7,770
Closed -$728K

Similar funds

Palisade Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Palisade Capital Management held 381 positions worth $3.77B, up 5.3% from $3.58B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Palisade Capital Management withdrew a net $586M in Q4 2023, closing 12 positions and reducing 124 holdings. Its most notable exit was Pediatrix Medical, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Palisade Capital Management opened a new position in iShares Russell 2000 ETF worth $24.1M.

  • Palisade Capital Management's largest Q4 2023 buy was iShares Russell 2000 ETF: 119,870 shares worth $24.1M.
  • Palisade Capital Management added most to Veralto in Q4 2023, an estimated $5.55M increase.
  • Palisade Capital Management's biggest Q4 2023 reduction was Applied Industrial Technologies, cutting an estimated $17.9M.
  • Palisade Capital Management fully exited Pediatrix Medical in Q4 2023, selling an estimated $10.5M.
  • Palisade Capital Management's ten largest holdings make up 15% of its $3.77B portfolio in Q4 2023.
  • Palisade Capital Management opened 11 new positions and closed 12 in Q4 2023.
  • Palisade Capital Management's portfolio value rose 5.3% quarter-over-quarter to $3.77B.

Based on Palisade Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.